慢性腎臓病治療薬の世界市場レポート2020

• 英文タイトル：Global Chronic Kidney Disease Drugs Sales Market Report 2020

• レポートコード：MRC2102QY2962 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界の慢性腎臓病治療薬市場について種類別（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他）、用途別（病院、専門クリニック）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・慢性腎臓病治療薬市場の概要 ・世界の主要地域別慢性腎臓病治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の慢性腎臓病治療薬市場規模2015-2026：種類別（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他） ・世界の慢性腎臓病治療薬市場規模2015-2026：用途別（病院、専門クリニック） ・慢性腎臓病治療薬の米国市場規模2015-2020 ・慢性腎臓病治療薬のヨーロッパ市場規模2015-2020 ・慢性腎臓病治療薬の中国市場規模2015-2020 ・慢性腎臓病治療薬の日本市場規模2015-2020 ・慢性腎臓病治療薬の東南アジア市場規模2015-2020 ・慢性腎臓病治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・慢性腎臓病治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・慢性腎臓病治療薬の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Chronic Kidney Disease Drugs Market
The global Chronic Kidney Disease Drugs market size is projected to reach US$ 12450 million by 2026, from US$ 11220 million in 2020, at a CAGR of 1.8% during 2021-2026.

Global Chronic Kidney Disease Drugs Scope and Market Size
The global Chronic Kidney Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Chronic Kidney Disease Drugs market is segmented into
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others

Segment by Application, the Chronic Kidney Disease Drugs market is segmented into
Hospitals
Specialty Clinics

The Chronic Kidney Disease Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Chronic Kidney Disease Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Chronic Kidney Disease Drugs Market Share Analysis
Chronic Kidney Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease Drugs business, the date to enter into the Chronic Kidney Disease Drugs market, Chronic Kidney Disease Drugs product introduction, recent developments, etc.

The major vendors covered:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries

レポート目次

---

1 Chronic Kidney Disease Drugs Market Overview
1.1 Chronic Kidney Disease Drugs Product Scope
1.2 Chronic Kidney Disease Drugs Segment by Type
1.2.1 Global Chronic Kidney Disease Drugs Sales by Type (2020-2026)
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blockers
1.2.4 Beta Blockers
1.2.5 Others
1.3 Chronic Kidney Disease Drugs Segment by Application
1.3.1 Global Chronic Kidney Disease Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Chronic Kidney Disease Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Chronic Kidney Disease Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Chronic Kidney Disease Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Chronic Kidney Disease Drugs Price Trends (2015-2026)

2 Chronic Kidney Disease Drugs Estimate and Forecast by Region
2.1 Global Chronic Kidney Disease Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Chronic Kidney Disease Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Chronic Kidney Disease Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Chronic Kidney Disease Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
2.4.3 China Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
2.4.6 India Chronic Kidney Disease Drugs Estimates and Projections (2015-2026)
3 Global Chronic Kidney Disease Drugs Competition Landscape by Players
3.1 Global Top Chronic Kidney Disease Drugs Players by Sales (2015-2020)
3.2 Global Top Chronic Kidney Disease Drugs Players by Revenue (2015-2020)
3.3 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease Drugs as of 2019)
3.4 Global Chronic Kidney Disease Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Chronic Kidney Disease Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Chronic Kidney Disease Drugs Players (Opinion Leaders)
4 Global Chronic Kidney Disease Drugs Market Size by Type
4.1 Global Chronic Kidney Disease Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Chronic Kidney Disease Drugs Price by Type (2015-2020)
4.2 Global Chronic Kidney Disease Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Chronic Kidney Disease Drugs Price Forecast by Type (2021-2026)
5 Global Chronic Kidney Disease Drugs Market Size by Application
5.1 Global Chronic Kidney Disease Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Chronic Kidney Disease Drugs Price by Application (2015-2020)
5.2 Global Chronic Kidney Disease Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)

6 United States Chronic Kidney Disease Drugs Market Facts & Figures
6.1 United States Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
6.2 United States Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
6.3 United States Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

7 Europe Chronic Kidney Disease Drugs Market Facts & Figures
7.1 Europe Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

8 China Chronic Kidney Disease Drugs Market Facts & Figures
8.1 China Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
8.2 China Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
8.3 China Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

9 Japan Chronic Kidney Disease Drugs Market Facts & Figures
9.1 Japan Chronic Kidney Disease Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

10 Southeast Asia Chronic Kidney Disease Drugs Market Facts & Figures
10.1 Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

11 India Chronic Kidney Disease Drugs Market Facts & Figures
11.1 India Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
11.2 India Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
11.3 India Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Chronic Kidney Disease Drugs Business
12.1 Keryx Biopharmaceuticals, Inc
12.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
12.1.2 Keryx Biopharmaceuticals, Inc Business Overview
12.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
12.1.5 Keryx Biopharmaceuticals, Inc Recent Development
12.2 Kissei Pharmaceutical Co., Ltd
12.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
12.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
12.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Products Offered
12.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Business Overview
12.3.3 AbbVie Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Chronic Kidney Disease Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Chronic Kidney Disease Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 F. Hoffmann-La Roche Ltd
12.6.1 F. Hoffmann-La Roche Ltd Corporation Information
12.6.2 F. Hoffmann-La Roche Ltd Business Overview
12.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Ltd Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Chronic Kidney Disease Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Business Overview
12.8.3 AstraZeneca Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Chronic Kidney Disease Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Amgen
12.9.1 Amgen Corporation Information
12.9.2 Amgen Business Overview
12.9.3 Amgen Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amgen Chronic Kidney Disease Drugs Products Offered
12.9.5 Amgen Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Corporation Information
12.10.2 Teva Pharmaceutical Industries Business Overview
12.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Recent Development

13 Chronic Kidney Disease Drugs Manufacturing Cost Analysis
13.1 Chronic Kidney Disease Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chronic Kidney Disease Drugs
13.4 Chronic Kidney Disease Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chronic Kidney Disease Drugs Distributors List
14.3 Chronic Kidney Disease Drugs Customers

15 Market Dynamics
15.1 Chronic Kidney Disease Drugs Market Trends
15.2 Chronic Kidney Disease Drugs Opportunities and Drivers
15.3 Chronic Kidney Disease Drugs Market Challenges
15.4 Chronic Kidney Disease Drugs Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Chronic Kidney Disease Drugs Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Chronic Kidney Disease Drugs Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Chronic Kidney Disease Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Chronic Kidney Disease Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Chronic Kidney Disease Drugs Revenue Share by Region (2015-2020)
Table 8. Global Chronic Kidney Disease Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Chronic Kidney Disease Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Chronic Kidney Disease Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Chronic Kidney Disease Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Chronic Kidney Disease Drugs Sales Share by Company (2015-2020)
Table 14. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Chronic Kidney Disease Drugs Revenue Share by Company (2015-2020)
Table 16. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease Drugs as of 2019)
Table 17. Global Chronic Kidney Disease Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Chronic Kidney Disease Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Chronic Kidney Disease Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Chronic Kidney Disease Drugs Players
Table 22. Global Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 24. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Chronic Kidney Disease Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Chronic Kidney Disease Drugs Sales Share by Type (2021-2026)
Table 27. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Chronic Kidney Disease Drugs Revenue Share by Type (2021-2026)
Table 29. Global Chronic Kidney Disease Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)
Table 32. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Chronic Kidney Disease Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Chronic Kidney Disease Drugs Sales Share by Application (2021-2026)
Table 36. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Chronic Kidney Disease Drugs Revenue Share by Application (2021-2026)
Table 38. Global Chronic Kidney Disease Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 51. China Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 53. China Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 55. China Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 69. India Chronic Kidney Disease Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Chronic Kidney Disease Drugs Sales Market Share by Company (2015-2020)
Table 71. India Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 73. India Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 75. Keryx Biopharmaceuticals, Inc Corporation Information
Table 76. Keryx Biopharmaceuticals, Inc Description and Business Overview
Table 77. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product
Table 79. Keryx Biopharmaceuticals, Inc Recent Development
Table 80. Kissei Pharmaceutical Co., Ltd Corporation Information
Table 81. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 82. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product
Table 84. Kissei Pharmaceutical Co., Ltd Recent Development
Table 85. AbbVie Corporation Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. AbbVie Chronic Kidney Disease Drugs Product
Table 89. AbbVie Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Chronic Kidney Disease Drugs Product
Table 94. GlaxoSmithKline Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sanofi Chronic Kidney Disease Drugs Product
Table 99. Sanofi Recent Development
Table 100. F. Hoffmann-La Roche Ltd Corporation Information
Table 101. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 102. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product
Table 104. F. Hoffmann-La Roche Ltd Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Pfizer Chronic Kidney Disease Drugs Product
Table 109. Pfizer Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. AstraZeneca Description and Business Overview
Table 113. AstraZeneca Chronic Kidney Disease Drugs Product
Table 114. AstraZeneca Recent Development
Table 115. Amgen Corporation Information
Table 116. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Amgen Description and Business Overview
Table 118. Amgen Chronic Kidney Disease Drugs Product
Table 119. Amgen Recent Development
Table 120. Teva Pharmaceutical Industries Corporation Information
Table 121. Teva Pharmaceutical Industries Description and Business Overview
Table 122. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product
Table 124. Teva Pharmaceutical Industries Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Chronic Kidney Disease Drugs Distributors List
Table 128. Chronic Kidney Disease Drugs Customers List
Table 129. Chronic Kidney Disease Drugs Market Key Trends
Table 130. Chronic Kidney Disease Drugs Key Opportunities and Drivers
Table 131. Chronic Kidney Disease Drugs Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Kidney Disease Drugs Product Picture
Figure 2. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chronic Kidney Disease Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Specialty Clinics Examples
Figure 8. Global Chronic Kidney Disease Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Chronic Kidney Disease Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Chronic Kidney Disease Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Chronic Kidney Disease Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Chronic Kidney Disease Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Chronic Kidney Disease Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Chronic Kidney Disease Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Chronic Kidney Disease Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Chronic Kidney Disease Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Chronic Kidney Disease Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Chronic Kidney Disease Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Chronic Kidney Disease Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Chronic Kidney Disease Drugs Players Market Share by Revenue in Chronic Kidney Disease Drugs 2015 & 2019
Figure 26. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Chronic Kidney Disease Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Chronic Kidney Disease Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Chronic Kidney Disease Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 32. United States Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 33. Europe Chronic Kidney Disease Drugs Sales Market Share by Company in 2019
Figure 34. Europe Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 35. Europe Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 36. China Chronic Kidney Disease Drugs Sales Market Share by Company in 2019
Figure 37. China Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 38. China Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 39. Japan Chronic Kidney Disease Drugs Sales Market Share by Company in 2019
Figure 40. Japan Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 41. Japan Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 45. India Chronic Kidney Disease Drugs Sales Market Share by Company in 2019
Figure 46. India Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 47. India Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Chronic Kidney Disease Drugs
Figure 50. Manufacturing Process Analysis of Chronic Kidney Disease Drugs
Figure 51. Chronic Kidney Disease Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

---